Cargando…
RUNX2 promotes gastric cancer progression through the transcriptional activation of MGAT5 and MMP13
INTRODUCTION: RUNX2 is overexpressed in gastric cancer but the mechanism(s) through which it promotes tumor progression remain undefined. Here, we investigated the role of RUNX2 on gastric cancer pathogenesis at the molecular level. METHODS: The qRT-PCR and western bolt were utilized to examine the...
Autores principales: | Wang, Ying, Tan, Zhibo, Li, Xiaoyu, Zhang, Lili, Pei, Xiaojuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226684/ https://www.ncbi.nlm.nih.gov/pubmed/37256183 http://dx.doi.org/10.3389/fonc.2023.1133476 |
Ejemplares similares
-
DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes
por: Takahashi, Atsushi, et al.
Publicado: (2017) -
ISLR interacts with MGAT5 to promote the malignant progression of human gastric cancer AGS cells
por: Zuo, Bin, et al.
Publicado: (2023) -
Loss of Barx1 promotes hepatocellular carcinoma metastasis through up-regulating MGAT5 and MMP9 expression and indicates poor prognosis
por: Wang, Guodong, et al.
Publicado: (2017) -
MiR-23a transcriptional activated by Runx2 increases metastatic potential of mouse hepatoma cell via directly targeting Mgat3
por: Huang, Huang, et al.
Publicado: (2018) -
Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012)